Grant Avenue Capital Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Grant Avenue Capital has acquired 3 companies.

Grant Avenue Capital’s most common sectors for investment arehealthcare services (75%) and life science (25%) . The Firm’s most common investment types include divestiture (75%) and consolidation (25%). In total, Grant Avenue Capital has invested in 4 US states.

Join Mergr to view Grant Avenue Capital’s full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity4
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3
  • M&A Advisors 3

Grant Avenue Capital

Grant Avenue Capital LLC

444 Madison Ave., Suite #3300,
New York, New York 10022
United States
(212) 630-8935
www.grantavecap.com
info@grantavecap.com

Grant Avenue Capital is a private equity firm focused on middle-market healthcare companies in North America. Grant Avenue seeks long-term partnerships with founders and management teams in companies with EBITDA of $5 to $25 million. Specific sectors of interest include home-based care, retail health and wellness, healthcare products, and pharma devices and services. The Firm considers control buy-outs, buy and builds, corporate carve-outs, joint-control partnerships and special situations. Grant Avenue Capital was founded in 2017 and is headquartered in New York, New York.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Divestiture, Recapitalization, Special Situations/Distressed, Stake Purchase

Geographic Preferences: East US, Midwest US, South US, West US, Canada

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA 5 25
Investment Size - -
Enterprise Value 50 250
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.8/yr) # - 1 2 1 - - 4
Sell (0.0/yr) # - - - - - - 0
  4

Most Recent M&A

Company Date Value Type
Helios Clinical Research 2022-11-17 - Consolidation
New York, New York · www.heliosclinical.com
Ovation Healthcare 2021-06-01 - Divestiture
Brentwood, Tennessee · www.ovationhc.com
Fortis Home Health & Hospice 2021-01-25 - Divestiture
, Alabama · www.fortishh.com
H2 Health 2020-02-04 - Divestiture
Jacksonville, Florida · www.h2health.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Fortis Home Health & Hospice 2021-01-25 Hearts for Hospice and Home Health 2021-04-27 2
, Alabama · www.fortishh.com American Fork, Utah · www.heartsforhospiceandhomehealth.com
H2 Health 2020-02-04 MileStone Staffing, Inc. 2020-02-04 1
Jacksonville, Florida · www.h2health.com Richardson, Texas · www.milestonestaffing.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 3 (75%) - 3 (75%) -
Life Science 1 (25%) - 1 (25%) -
Total 4 - 4 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 4 (100%) - 4 (100%) -
  Tennessee 1 (25%) - 1 (25%) -
  New York 1 (25%) - 1 (25%) -
  Florida 1 (25%) - 1 (25%) -
  Alabama 1 (25%) - 1 (25%) -
Total 4 - 4 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Divestiture 3 (75%) - 3 (75%) -
Consolidation 1 (25%) - 1 (25%) -
Total 4 - 4 -

Top M&A Advisors

Financial Deals
Triple Tree LLC
 1
Brentwood Capital Advisors
 1
Lincoln International
 1

M&A Connections

Deals
Acquired from
Strategic(s)
75%
3 (75%)

Investor Summary

Investor Type

Private Equity Firm

Size

Middle-Market

Established

2017

Specialist/Generalist

Specialist

Leadership

Buddy Gumina

Founder & Managing Partner

Preston Brice

Partner

Teresa Johnson

Operating Partner

Stew Jamieson

Director, Business Development

FAQ

When was Grant Avenue Capital founded?

Grant Avenue Capital was founded in 2017.

What type of investor is Grant Avenue Capital?

Grant Avenue Capital is a private equity firm.

Where is Grant Avenue Capital headquartered?

Grant Avenue Capital is headquartered in New York, New York.

 Subscribe to unlock this and 208,107
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal